Skip Navigation


JAC Advance Access originally published online on September 24, 2009
Journal of Antimicrobial Chemotherapy 2009 64(6):1299-1306; doi:10.1093/jac/dkp345
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
64/6/1299    most recent
dkp345v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Denis, O.
Right arrow Articles by Struelens, M. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, O.
Right arrow Articles by Struelens, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium

Olivier Denis1,2,*,{dagger}, Bea Jans3,{dagger}, Ariane Deplano1, Claire Nonhoff1, Raf De Ryck1, Carl Suetens3,{ddagger} and Marc J. Struelens1,2

1 Laboratoire de Référence MRSA-Staphylocoques, Department of Microbiology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium 2 Unité d'Epidémiologie des Maladies Infectieuses, Ecole de Santé Publique, Université Libre de Bruxelles, Brussels, Belgium 3 Epidemiology Unit, Scientific Institute of Public Health, Brussels, Belgium

Received 16 April 2009; returned 23 June 2009; revised 25 August 2009; accepted 25 August 2009


* Corresponding author. Service de Microbiologie, Hôpital Erasme, 808, route de Lennik, 1070 Brussels, Belgium. Tel: +32-2-555-69-71; Fax: +32-2-555-31-10; E-mail: odenis{at}ulb.ac.be

Objectives: A national survey was conducted to determine the prevalence, risk factors and molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) carriage among nursing home (NH) residents in Belgium.

Methods: A random stratified, cross-sectional prevalence survey was conducted in NH residents who were screened for MRSA carriage by multisite enriched culture. Characteristics of NHs and residents were collected by a questionnaire survey and analysed by two-stage logistic regression modelling. MRSA isolates were genotyped by PFGE, staphylococcal cassette chromosome mec (SCCmec) typing, multilocus sequence typing (MLST) and resistance genes.

Results: Of 2953 residents screened in 60 NHs, 587 (19.9%) were MRSA carriers. Risk factors included hospital contact, antibiotic exposure, impaired mobility and skin lesions at the resident level, and lack of MRSA surveillance, lack of antibiotic therapeutic formulary and the combination of less-developed infection control activities and a high ratio of physicians to residents at the institution level. MRSA isolates showed eight major types, three of which were predominant: B2-ST45-SCCmec IV (49%; where ST stands for sequence type); A21-ST8-SCCmec IV (13%); and A20-ST8-SCCmec IV (10%). Each was recovered in 55, 21 and 25 NHs, respectively. The geographical distribution of NH genotypes paralleled that of acute-care hospitals.

Conclusions: A high prevalence of MRSA carriage in NH residents was associated with hospital care, co-morbidities and less-developed coordination of institutional care. The predominant MRSA strains from NH residents and hospitalized patients of the same area were identical. Strengthening and coordination of MRSA surveillance and control activities are warranted within and between NHs and hospitals.

Keywords: prevalence , risk factors , molecular epidemiology


{dagger} These authors contributed equally to this work.

{ddagger} Present address: European Centre for Disease Prevention and Control, Stockholm, Sweden.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.